UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Patient-, disease- and treatment-related factors implicated in late neuroendocrine morbidity after paediatric optic pathway gliomas

Gan, HW; (2013) Patient-, disease- and treatment-related factors implicated in late neuroendocrine morbidity after paediatric optic pathway gliomas. Masters thesis , UCL Institute of Child Health.

Full text not available from this repository.

Abstract

Background. 30-50% of paediatric low-grade gliomas affect the optic pathway or suprasellar midline (OPGs), resulting in significant tumour- or treatment-related neuroendocrine dysfunction despite their benign histology. This study uniquely reports on the predictors of endocrinopathy in a large single-centre OPG cohort over 30 years of follow-up. Methods. Retrospective case note review of 166 OPG patients at Great Ormond Street Hospital between 1980 and 2010. Results. Patients were of median age 4.9 (0.2-15.4) years at diagnosis and followed-up for a median of 8.2 (0.04-29.7) years. 20-year overall, progression-free and endocrine event-free (EEFS) survival were 84.9%, 49.0% and 20.8% respectively, with EEFS falling up to 15 years from diagnosis, being independently reduced by hypothalamochiasmatic tumour involvement (p=0.008) more than radiotherapy (p=0.03). Conversely, the number of deficits was increased more by radiotherapy (p=0.007) than hypothalamic involvement (p=0.02), with progression over time. EEFS was lower in more recent treatment eras (p=0.01). GH deficiency was commonest (41.0%), followed by central precocious puberty (26.0%), gonadotrophin deficiency (20.4%), ACTH deficiency (14.5%), TSH deficiency (13.3%) and posterior pituitary dysfunction (PPD, 13.3%). PPD was increased by repeated surgeries (including shunt insertions or biopsies, p=0.03). 32.5% developed obesity, particularly those with hypothalamic tumours (p=0.02). Conclusions. This long-term multivariate analysis of OPG survivors provides new evidence suggesting that tumour location is more predictive of early endocrinopathy than irradiation, but radiotherapy increases its severity. It challenges the benefit of more recent treatment strategies, which do not improve survival but compound this risk, particularly as even minor surgery can result in life-threatening PPD.

Type: Thesis (Masters)
Title: Patient-, disease- and treatment-related factors implicated in late neuroendocrine morbidity after paediatric optic pathway gliomas
Event: UCL Institute of Child Health
Keywords: Optic pathway glioma, juvenile pilocytic astrocytoma, low-grade, neuroendocrine late effects, survival
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
URI: https://discovery.ucl.ac.uk/id/eprint/1447831
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item